Regina Toomey Bueno, former oncology admin at Garnet Health, had good insurance, lots of support, and 2 cancer diagnoses. She ...

In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...

In the intricate web of healthcare funding, where government resources are finite and priorities often shift with political tides, some diseases receive significantly more attention and financial ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

Action Month, created, according to the International Myeloma Foundation (IMF), “to draw attention to the disease and inspire ...

March has been declared Multiple Myeloma Month in BC following the efforts of an advocacy group in Abbotsford. Multiple ...

We believe Genmab is in solid financial health. At the end of 2024, Genmab held DKK 9.9 billion in cash and cash equivalents. After turning profitable in 2013, the company has steadily increased its ...

DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...

Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...

Worship Walker County will hold its Women’s Breakfast on Friday, March 21 at 8:30 a.m. at Morning Pointe at Happy Valley. The ...

Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...